Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI
Asan Medical Center
Asan Medical Center
Centre Leon Berard
Instituto Ecuatoriano de Enfermedades Digestivas
Australasian Gastro-Intestinal Trials Group
Peking University
Sichuan Provincial People's Hospital
Hospital Universitario Virgen de la Arrixaca
RenJi Hospital
RenJi Hospital
Peking Union Medical College Hospital
The First Affiliated Hospital with Nanjing Medical University
Zagazig University
M.D. Anderson Cancer Center
Cttq
Shanghai Zhongshan Hospital
Sun Yat-sen University
First Affiliated Hospital Xi'an Jiaotong University
Jiangsu HengRui Medicine Co., Ltd.
First Affiliated Hospital Xi'an Jiaotong University
Assaf-Harofeh Medical Center
Universität Duisburg-Essen
Fondazione del Piemonte per l'Oncologia
RenJi Hospital
Unity Health Toronto
Peking University Cancer Hospital & Institute
Assistance Publique Hopitaux De Marseille
First Affiliated Hospital, Sun Yat-Sen University
National Health Research Institutes, Taiwan
Shanghai Zhongshan Hospital
European Organisation for Research and Treatment of Cancer - EORTC
Threshold Pharmaceuticals
Nanfang Hospital, Southern Medical University
National Cancer Institute (NCI)
Radboud University Medical Center
Maisonneuve-Rosemont Hospital